CASELLA, Michela
 Distribuzione geografica
Continente #
NA - Nord America 10.813
AS - Asia 3.512
EU - Europa 3.128
SA - Sud America 864
AF - Africa 264
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 4
AN - Antartide 1
Totale 18.604
Nazione #
US - Stati Uniti d'America 10.678
SG - Singapore 1.376
HK - Hong Kong 839
BR - Brasile 744
CN - Cina 713
RU - Federazione Russa 675
IE - Irlanda 567
IT - Italia 419
DE - Germania 353
SE - Svezia 249
UA - Ucraina 212
GB - Regno Unito 204
VN - Vietnam 204
FR - Francia 182
IN - India 147
MA - Marocco 142
CA - Canada 67
CI - Costa d'Avorio 62
FI - Finlandia 60
AR - Argentina 52
MX - Messico 45
AT - Austria 40
BD - Bangladesh 36
PL - Polonia 34
ZA - Sudafrica 34
NL - Olanda 33
JP - Giappone 32
TR - Turchia 26
RO - Romania 25
ES - Italia 24
IQ - Iraq 24
ID - Indonesia 21
EC - Ecuador 18
BE - Belgio 17
EU - Europa 17
JO - Giordania 11
VE - Venezuela 11
CO - Colombia 10
LT - Lituania 10
PK - Pakistan 10
AE - Emirati Arabi Uniti 9
SA - Arabia Saudita 8
CL - Cile 7
PE - Perù 7
UY - Uruguay 7
EG - Egitto 6
NP - Nepal 6
PY - Paraguay 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
KR - Corea 5
KZ - Kazakistan 5
TN - Tunisia 5
AU - Australia 4
HN - Honduras 4
PT - Portogallo 4
AL - Albania 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
CH - Svizzera 3
CR - Costa Rica 3
DZ - Algeria 3
JM - Giamaica 3
KE - Kenya 3
KW - Kuwait 3
PA - Panama 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
IL - Israele 2
IR - Iran 2
LB - Libano 2
MU - Mauritius 2
PH - Filippine 2
PR - Porto Rico 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AQ - Antartide 1
BB - Barbados 1
BG - Bulgaria 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
KG - Kirghizistan 1
KH - Cambogia 1
LI - Liechtenstein 1
MD - Moldavia 1
ML - Mali 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
Totale 18.597
Città #
Ashburn 1.512
Singapore 957
Des Moines 922
Hong Kong 835
Fairfield 827
Chandler 759
Jacksonville 654
Dallas 576
Dublin 558
Boardman 396
Woodbridge 373
Wilmington 345
Seattle 332
Houston 318
The Dalles 293
Cambridge 279
New York 227
Lawrence 195
Princeton 195
Beijing 189
Los Angeles 170
San Mateo 169
Ann Arbor 163
Moscow 107
Pune 104
Hefei 95
Ancona 87
San Diego 84
São Paulo 82
Munich 80
Washington 77
Ho Chi Minh City 72
Chicago 67
London 64
Abidjan 62
Redmond 61
Columbus 56
Hanoi 47
Buffalo 45
Turin 41
Brooklyn 39
Nuremberg 34
Santa Clara 34
Guangzhou 32
Tokyo 31
Turku 31
Orem 30
Warsaw 30
Helsinki 29
Shanghai 28
Stockholm 28
Boston 24
Denver 24
Frankfurt am Main 22
Manchester 22
Atlanta 21
Chennai 21
Council Bluffs 21
Montreal 21
Rio de Janeiro 21
Johannesburg 20
Mexico City 20
Phoenix 20
Salt Lake City 20
Vienna 20
Poplar 19
San Francisco 19
Ankara 18
Milan 18
Belo Horizonte 17
Curitiba 17
Norwalk 16
San Jose 16
Tolentino 16
Brussels 15
Rome 14
Wuhan 14
Amsterdam 13
Tampa 13
Toronto 13
Kilburn 12
Falls Church 11
Kazan' 11
Paris 11
Porto Alegre 11
Amman 10
Nanjing 10
Secaucus 10
Shenzhen 10
Cape Town 9
Dhaka 9
Guarulhos 9
Guayaquil 9
Miami 9
Centro 8
Haiphong 8
Jiaxing 8
Jinhua 8
Pelotas 8
Querétaro 8
Totale 13.545
Nome #
Cardiac arrhythmia catheter ablation procedures guided by x-ray imaging: N-acetylcysteine protection against radiation-induced cellular damage (CARAPACE study): study design 180
Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC Task Force Criteria 169
Recent advances in three-dimensional electroanatomical mapping guidance for the ablation of complex atrial and ventricular arrhythmias 164
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on a Tertiary-Level Electrophysiology Laboratory in Italy 160
Long-Term Arrhythmic Risk Assessment in Biopsy-Proven Myocarditis 156
Characteristics of Patients With Arrhythmogenic Left Ventricular Cardiomyopathy: Combining Genetic and Histopathologic Findings 155
Differences in underlying cardiac substrate among S-ICD recipients and its impact on long-term device-related outcomes: Real-world insights from the iSUSI registry 149
A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: The Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial 149
Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Arrhythmia-free survival after endo-epicardial substrate based mapping and ablationablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy arrhythmia-free survival after endo-epicardial substrate based mapping and ablation 147
Clinical management of electrical storm 139
Ablation for longstanding permanent atrial fibrillation: Results from a randomized study comparing three different strategies 132
Cyclophilin a in arrhythmogenic cardiomyopathy cardiac remodeling 131
Ablation Index as a predictor of long-term efficacy in premature ventricular complex ablation: A regional target value analysis 124
Pulsed field vs very high-power short-duration radiofrequency ablation for atrial fibrillation: Results of a multicenter, real-world experience 123
Role of cardiac imaging in patients undergoing catheter ablation of ventricular tachycardia 122
Prior myocarditis and ventricular arrhythmias: the importance of scar pattern 118
Ablation of perimitral flutter following catheter ablation of atrial fibrillation: Impact on outcomes from a randomized study (PROPOSE) 116
Diagnostic Yield of Electroanatomic Voltage Mapping in Guiding Endomyocardial Biopsies 115
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial 113
Acute outcome after a single cryoballoon ablation: Comparison between Arctic Front Advance and Arctic Front Advance PRO 113
Procedural sedation for direct current cardioversion: a feasibility study between two management strategies in the emergency department 112
"Near-zero" fluoroscopic exposure in supraventricular arrhythmia ablation using the EnSite NavX" mapping system: Personal experience and review of the literature 110
An ablation index operator-independent approach to improve efficacy in atrial fibrillation ablation at 24-month follow-up: a single center experience 107
Additional diagnostic value of cardiac magnetic resonance feature tracking in patients with biopsy-proven arrhythmogenic cardiomyopathy 107
Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy the VISTA Randomized Multicenter Trial 106
Novel risk calculator performance in athletes with arrhythmogenic right ventricular cardiomyopathy 106
Pathophysiology of Typical Atrial Flutter 105
Ablation Index Predicts Successful Ablation of Focal Atrial Tachycardia: Results of a Multicenter Study 105
Prospective use of ablation index for the ablation of right ventricle outflow tract premature ventricular contractions: a proof of concept study 104
Long-Term Outcomes of Near-Zero Radiation Ablation of Paroxysmal Supraventricular Tachycardia: A Comparison With Fluoroscopy-Guided Approach 103
A Closer Look at Incidental Findings on Cardiac Computed Tomography 102
Scar Homogenization Versus Limited-Substrate Ablation in Patients With Nonischemic Cardiomyopathy and Ventricular Tachycardia 102
Recurrence of atrial fibrillation post-ablation: which is the most effective approach for detection? 101
Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50 99
Worldwide Survey of COVID-19-Associated Arrhythmias 99
Cardiac imaging in athlete’s heart: The role of the radiologist 99
Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue 98
Prevalence and clinical significance of collateral findings detected by chest computed tomography in patients undergoing atrial fibrillation ablation 97
Exploring digenic inheritance in arrhythmogenic cardiomyopathy 95
Clinical and Molecular Data Define a Diagnosis of Arrhythmogenic Cardiomyopathy in a Carrier of a Brugada-Syndrome-Associated PKP2 Mutation 94
Role of Intracardiac echocardiography in Atrial Fibrillation Ablation 94
"NEAR ZERO" FLUOROSCOPIC EXPOSURE IN SUPRAVENTRICULAR ARRHYTHMIA ABLATION USING THE ENSITE NAVXTM MAPPING SYSTEM 94
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring With Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 93
Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis 93
Ventricular arrhythmias induced by long-term use of ephedrine in two competitive athletes 92
Rationale and design of the NO-PARTY trial: Near-zero fluoroscopic exposure during catheter ablation of supraventricular arrhythmias in young patients 92
Myocardial inflammation, sports practice, and sudden cardiac death: 2021 update 92
Epicardial ablation as a bailout in electrical storm? 91
An atlas of radioscopic catheter placement for the electrophysiologist 90
Concealed cardiomyopathies in competitive athletes with ventricular arrhythmias and an apparently normal heart: Role of cardiac electroanatomical mapping and biopsy 89
Compassionate drug use for patients with transthyretin amyloid cardiomyopathy 89
Catheter ablation of atrial fibrillation: Randomized controlled trials and registries, a look back and the view forward 88
Combined use of cryoballoon and focal open-irrigation radiofrequency ablation for treatment of persistent atrial fibrillation: Results from a pilot study 88
CMR for Identifying the Substrate of Ventricular Arrhythmia in Patients With Normal Echocardiography 87
Sports Activity and Arrhythmic Risk in Cardiomyopathies and Channelopathies: A Critical Review of European Guidelines on Sports Cardiology in Patients with Cardiovascular Diseases 87
Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: A systematic review and meta-analysis 86
Pulmonary-vein isolation for atrial fibrillation in patients with heart failure 86
Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: Results from a prospective risk stratification study 85
Electroanatomic and histologic findings in patients with clinical and instrumental diagnosis of arrhythmogenic right ventricular cardiomyopathy 85
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 83
X-ray exposure in cardiac electrophysiology: A retrospective analysis in 8150 patients over 7 years of activity in a modern, large-volume laboratory 83
Feasibility of Combined Unipolar and Bipolar Voltage Maps to Improve Sensitivity of Endomyocardial Biopsy 83
Electroanatomical mapping systems and intracardiac echo integration for guided endomyocardial biopsy 83
Atrial Flutters in Adults with Congenital Heart Disease 82
Different Phases of Disease in Lymphocytic Myocarditis: Clinical and Electrophysiological Characteristics 81
Electrocardiographic Approach to Atrial Flutter: Classifications and Differential Diagnosis 81
Atrial fibrillation ablation strategies for paroxysmal patients randomized comparison between different techniques 81
Long term follow up after radiofrequency catheter ablation of atrial fibrillation: role of the acute procedure outcome and of the clinical presentation 81
Difficult case of a trans-septal puncture: Use of a "SafeSept" guidewire 81
Endomyocardial biopsy: The forgotten piece in the arrhythmogenic cardiomyopathy puzzle 81
Efficacy of Catheter Ablation for Atrial Arrhythmias in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy-A Multicenter Study 80
Atrial Flutter in Particular Patient Populations 80
Cardiac resynchronization therapy in patients with mild heart failure: A systematic review and meta-analysis 80
Acute Kidney Injury Resulting From Hemoglobinuria After Pulsed-Field Ablation in Atrial Fibrillation: Is it Preventable? 79
Safety and Efficacy of Stereotactic Arrhythmia Radioablation for the Treatment of Ventricular Tachycardia: A Systematic Review 79
Right ventricular substrate mapping using the Ensite Navx system: Accuracy of high-density voltage map obtained by automatic point acquisition during geometry reconstruction 79
Comparison of cardiac computed tomography versus cardiac magnetic resonance for characterization of left atrium anatomy before radiofrequency catheter ablation of atrial fibrillation 79
Derivation and Validation of a Clinical Score for Predicting Postoperative Atrial Fibrillation in Noncardiac Elective Surgery (the HART Score) 78
Implantable defibrillator-detected heart failure status predicts ventricular tachyarrhythmias 78
Characteristics and Clinical Value of Electroanatomic Voltage Mapping in Cardiac Amyloidosis 78
Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation 78
The effects of gender on electrical therapies for the heart: Procedural considerations, results and complications 78
Clinical and inflammatory predictors of occurrence of ventricular tachycardia and ventricular fibrillation in madit II-like patients 78
pregnant women with drug-refractory supraventricular tachyarrhythmias. Catheter ablation during pregnancy 78
Neuropeptide Y promotes adipogenesis of human cardiac mesenchymal stromal cells in arrhythmogenic cardiomyopathy 77
Novel Application of 3-Dimensional Real-Time Cardiac Imaging to Guide Stem Cell-Based Therapy 77
Detection of concealed structural heart disease by imaging in patients with apparently idiopathic premature ventricular complexes: A review of current literature 77
HEART RATE VARIABILITY AND THE SUBSTRATE FOR VENTRICULAR TACHYCARDIA IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 77
Heart rate turbulence: An useful non invasive risk predictor in patients with myotonic dystrophy type 1 77
Heart rate turbulence as a noninvasive risk predictor of ventricular tachyarrhythmias in myotonic dystrophy type 1 76
Electrical storm: A clinical and electrophysiological overview 76
Usefulness of intracardiac echocardiography for the diagnosis of cardiovascular implantable electronic device-related endocarditis 76
Letter by santangeli et al regarding article, high-density substrate mapping in brugada syndrome: Combined role of conduction and repolarization heterogeneities in arrhythmogenesis 76
High-power short-duration catheter ablation of atrial fibrillation: is it really a new era? Comparison between new and old radiofrequency contact force–sensing catheters 76
Role of tissue C-reactive protein in atrial cardiomyocytes of patients undergoing catheter ablation of atrial fibrillation: Pathogenetic implications 75
Prevention of phrenic nerve injury during epicardial ablation: Comparison of methods for separating the phrenic nerve from the epicardial surface 75
Safety and effectiveness of transvenous lead extraction in octogenarians 75
Uncommon ventricular tachycardia originating from an interventricular septal aneurism: Mapping and ablation guided by real-time image integration 75
Results from a single-blind, randomized study comparing the impact of different ablation approaches on long-term procedure outcome in coexistent atrial fibrillation and flutter (approval) 74
Characterization of the electroanatomic substrate in a case of noncompaction left ventricle 74
Totale 9.742
Categoria #
all - tutte 116.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.572


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.582 0 0 0 0 0 221 206 212 252 272 252 167
2021/20221.510 151 354 34 37 81 83 77 97 109 97 131 259
2022/20233.108 226 163 187 242 127 1.108 11 166 635 20 128 95
2023/20241.813 273 43 149 172 302 442 36 67 41 92 22 174
2024/20254.170 157 443 198 58 137 114 452 192 916 399 444 660
2025/20264.839 777 685 649 915 1.180 633 0 0 0 0 0 0
Totale 19.176